Mediator Is Tip Of EU Parliament's Probe Into EMA; Funding Held In Balance
This article was originally published in The Pink Sheet Daily
The European Parliament blocks approval of EMA's budget accounts, citing handling of Mediator and broader conflict of interest concerns.
You may also be interested in...
A trial has begun in France to investigate the roles of the French firm Servier and the former drug regulator AFSSAPS in the Mediator scandal, where an amphetamine-like drug was kept on the market despite mounting evidence of its cardiac side-effects.
Andreas Pott, who helped steer agency through Mediator scandal, becomes acting director again as irregularities in 2011’s recruitment process force departure of Guido Rasi – who himself might still get top job again once hiring process reboots.
EMA’s plans for access to clinical trials data not set to be ready until well into 2014.